| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,150 |
1,738 |
$654.44 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,812 |
1,537 |
$262.88 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,084 |
2,067 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
1,757 |
1,580 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
459 |
449 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
496 |
494 |
$0.00 |
| 85027 |
|
1,106 |
1,081 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
111 |
111 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
3,824 |
3,446 |
$0.00 |
| 99443 |
|
458 |
423 |
$0.00 |
| 82043 |
|
362 |
353 |
$0.00 |
| 1220F |
|
313 |
310 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
375 |
363 |
$0.00 |
| 3044F |
|
333 |
330 |
$0.00 |
| 90686 |
|
12 |
12 |
$0.00 |
| 3075F |
|
278 |
266 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
962 |
829 |
$0.00 |
| 4450F |
|
404 |
391 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
195 |
194 |
$0.00 |
| 3079F |
|
258 |
236 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
86 |
79 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
337 |
331 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
222 |
220 |
$0.00 |
| 86593 |
|
25 |
25 |
$0.00 |
| 3074F |
|
797 |
717 |
$0.00 |
| 3080F |
|
34 |
32 |
$0.00 |
| 87340 |
|
38 |
38 |
$0.00 |
| 86780 |
|
114 |
114 |
$0.00 |
| 81001 |
|
47 |
45 |
$0.00 |
| 1111F |
|
300 |
279 |
$0.00 |
| 86592 |
|
16 |
16 |
$0.00 |
| 90656 |
|
52 |
52 |
$0.00 |
| 86706 |
|
33 |
33 |
$0.00 |
| D0140 |
Limited oral evaluation - problem focused |
12 |
12 |
$0.00 |
| 86703 |
|
435 |
434 |
$0.00 |
| 80061 |
Lipid panel |
1,630 |
1,620 |
$0.00 |
| 99442 |
|
257 |
239 |
$0.00 |
| 90653 |
|
14 |
13 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
111 |
111 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
61 |
57 |
$0.00 |
| 3051F |
|
26 |
26 |
$0.00 |
| 3077F |
|
316 |
281 |
$0.00 |
| 3078F |
|
1,032 |
912 |
$0.00 |
| 82540 |
|
362 |
353 |
$0.00 |
| 82274 |
|
188 |
187 |
$0.00 |
| 84450 |
|
123 |
121 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
408 |
226 |
$0.00 |
| 3046F |
|
17 |
17 |
$0.00 |
| 84439 |
|
25 |
25 |
$0.00 |
| 84460 |
|
13 |
13 |
$0.00 |
| 90658 |
|
29 |
29 |
$0.00 |
| 86708 |
|
15 |
15 |
$0.00 |
| 85610 |
|
18 |
16 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
12 |
12 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
21 |
21 |
$0.00 |